Effects of multiple doses of montmorillonite, alone and in combination with activated charcoal, on the toxicokinetics of a dose of in rats

被引:0
作者
Heydarian, Fatemeh [1 ]
Moshiri, Mohammad [2 ]
Roohbakhsh, Ali [3 ,4 ]
Akaberi, Maryam [5 ]
Haghighizadeh, Atoosa [6 ]
Ghadiri, Ameneh [3 ]
Khorasani, Negar Yeganeh [7 ]
Etemad, Leila [6 ,8 ,9 ]
机构
[1] Mashhad Univ Med Sci, Fac Pharm, Mashhad, Iran
[2] Mashhad Univ Med Sci, Imam Reza Hosp, Dept Clin Toxicol, Mashhad, Iran
[3] Mashhad Univ Med Sci, Pharmaceut Technol Inst, Pharmaceut Res Ctr, Mashhad, Iran
[4] Mashhad Univ Med Sci, Sch Pharm, Dept Pharmacodynam & Toxicol, Mashhad, Iran
[5] Mashhad Univ Med Sci, Sch Pharm, Dept Pharmacognosy, Mashhad, Iran
[6] Mashhad Univ Med Sci, Sch Pharm, Dept Pharmaceut & Food Control, Mashhad, Iran
[7] Mashhad Univ Med Sci, Student Res Comm, Fac Pharm, Mashhad, Iran
[8] Mashhad Univ Med Sci, Med Toxicol Res Ctr, Mashhad, Iran
[9] Mashhad Univ Med Sci, Fac Med, Int UNESCO Ctr Hlth Related Basic Sci & Human Nutr, Mashhad, Iran
关键词
Antidotes; Bentonite; Charcoal; Digoxin; Poisoning; Toxicokinetics; HYPOKALEMIC MYOPATHY; DIGOXIN TOXICITY; PHARMACOKINETICS; APIXABAN;
D O I
10.22038/IJBMS.2023.66843.14661
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Objective(s): A narrow margin between the therapeutic and toxic doses of digoxin can result in an increased incidence of toxicity. Since digoxin has an enterohepatic cycle, multiple oral doses of absorbents like montmorillonite may be useful in the treatment of digoxin toxicity.Materials and Methods: In this study, 4 groups of 6 rats received intraperitoneal digoxin (1 mg/ kg), and half an hour later, distilled water (DW) or oral adsorbents, including montmorillonite (1 g/kg), activated charcoal (1 g/kg) (AC) alone or in combination in the ratio of 70:30. Half of the mentioned doses were also gavaged at 3 and 5.5 hr after digoxin injection. The serum level of digoxin, biochemical factors, and activity score were assessed during the experiment. Three control groups only received DW, montmorillonite, or AC.Results: All adsorbents were able to significantly decrease the serum level of digoxin compared to the digoxin+DW group (P<0.01). Only montmorillonite reversed the digoxin-induced hyperkalemia (P<0.05). Multiple dose administration of adsorbents also significantly reduced the digoxin area under the curve and half-life and increased digoxin clearance (P<0.05). However, there was no significant difference in the kinetic parameters between groups that received digoxin plus adsorbents.Conclusion: Multiple-dose of montmorillonite reversed digoxin toxicity and reduced serum digoxin levels by increasing the excretion and reducing the half-life. Montmorillonite has also corrected digoxin-induced hyperkalemia. Based on the findings, a multiple-dose regimen of oral montmorillonite could be a suitable candidate for reducing the toxicity issue associated with drugs like digoxin that undergo some degree of enterohepatic circulation.
引用
收藏
页码:906 / 911
页数:6
相关论文
共 27 条
  • [1] Efficacy of orally administered montmorillonite in myoglobinuric acute renal failure model in male rats
    Azad, Seyed Ali Hoseini
    Moshiri, Mohammad
    Roohbakhsh, Ali
    Shakeri, Abolfazl
    Shandiz, Ashkan Fatemi
    Etemad, Leila
    [J]. IRANIAN JOURNAL OF BASIC MEDICAL SCIENCES, 2023, 26 (07) : 753 - 759
  • [2] Mechanisms, manifestations, and management of digoxin toxicity in the modern era
    Bauman J.L.
    DiDomenico R.J.
    Galanter W.L.
    [J]. American Journal of Cardiovascular Drugs, 2006, 6 (2) : 77 - 86
  • [3] Digoxin toxicity in chronic renal failure: treatment by multiple dose activated charcoal intestinal dialysis
    Critchley, JAJH
    Critchley, LAH
    [J]. HUMAN & EXPERIMENTAL TOXICOLOGY, 1997, 16 (12): : 733 - 735
  • [4] Calcium for hyperkalaemia in digoxin toxicity
    Davey, M
    [J]. EMERGENCY MEDICINE JOURNAL, 2002, 19 (02) : 183 - 183
  • [5] Multiple-dose activated charcoal for treatment of yellow oleander poisoning: a single-blind, randomised, placebo-controlled trial
    de Silva, HA
    Fonseka, MMD
    Pathmeswaran, A
    Alahakone, DGS
    Ratnatilake, GA
    Gunatilake, SB
    Ranasinha, CD
    Lalloo, DG
    Aronson, JK
    de Silva, HJ
    [J]. LANCET, 2003, 361 (9373) : 1935 - 1938
  • [6] Fab antibody fragments - Some applications in clinical toxicology
    Flanagan, RJ
    Jones, AL
    [J]. DRUG SAFETY, 2004, 27 (14) : 1115 - 1133
  • [7] Frost C, 2017, CLIN PHARMACOL-ADV A, V9, P19, DOI 10.2147/CPAA.S115687
  • [8] Digoxin Toxicity and Use of Digoxin Immune Fab Insights From a National Hospital Database
    Hauptman, Paul J.
    Blume, Steven W.
    Lewis, Eldrin F.
    Ward, Suzanne
    [J]. JACC-HEART FAILURE, 2016, 4 (05) : 357 - 364
  • [9] ACCELERATION OF DIGOXIN CLEARANCE BY ACTIVATED-CHARCOAL
    LALONDE, RL
    DESHPANDE, R
    HAMILTON, PP
    MCLEAN, WM
    GREENWAY, DC
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1985, 37 (04) : 367 - 371
  • [10] DIAGNOSIS AND TREATMENT OF DIGOXIN TOXICITY
    LIP, GYH
    METCALFE, MJ
    DUNN, FG
    [J]. POSTGRADUATE MEDICAL JOURNAL, 1993, 69 (811) : 337 - 339